BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Department of Diabetes and Endocrinology, Outpatient Department 2, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
PLoS One. 2024 Jun 14;19(6):e0297601. doi: 10.1371/journal.pone.0297601. eCollection 2024.
Impaired awareness of hypoglycaemia (IAH) is a risk factor for severe hypoglycaemia (SH) in type 1 diabetes (T1D). Much of the IAH prevalence data comes from older studies where participants did not have the benefit of the latest insulins and technologies. This study surveyed the prevalence of IAH and SH in a tertiary adult clinic population and investigated the associated factors.
Adults (≥18 years) attending a tertiary T1D clinic completed a questionnaire, including a Gold and Clarke score. Background information was collected from health records.
189 people (56.1% female) with T1D (median [IQR] disease duration 19.3 [11.5, 29.1] years and age of 41.0 [29.0, 52.0] years) participated. 17.5% had IAH and 16.0% reported ≥1 episode of SH in the previous 12 months. Those with IAH were more likely to report SH (37.5% versus 11.7%, p = 0.001) a greater number of SH episodes per person (median [IQR] 0 [0,2] versus 0 [0,0] P<0.001) and be female (72.7% versus 52.6%, p = 0.036). Socio-economic deprivation was associated with IAH (p = 0.032) and SH (p = 0.005). Use of technology was the same between IAH vs aware groups, however, participants reporting SH were more likely to use multiple daily injections (p = 0.026). Higher detectable C-peptide concentrations were associated with a reduced risk of SH (p = 0.04).
Insulin pump and continuous glucose monitor use was comparable in IAH versus aware groups. Despite this, IAH remains a risk factor for SH and is prevalent in females and in older people. Socioeconomic deprivation was associated with IAH and SH, making this an important population to target for interventions.
低血糖意识受损(IAH)是 1 型糖尿病(T1D)严重低血糖(SH)的危险因素。大多数 IAH 患病率数据来自于早期研究,这些研究的参与者并未受益于最新的胰岛素和技术。本研究调查了三级成人诊所人群中 IAH 和 SH 的患病率,并探讨了相关因素。
参加三级 T1D 诊所的成年人(≥18 岁)完成了一份问卷,包括 Gold 和 Clarke 评分。背景信息从健康记录中收集。
共有 189 名 T1D 患者(56.1%为女性)参与了本研究(中位[IQR]病程 19.3[11.5,29.1]年,年龄 41.0[29.0,52.0]岁)。17.5%的患者存在 IAH,16.0%的患者报告在过去 12 个月内发生过≥1 次 SH。IAH 患者更有可能报告 SH(37.5% vs. 11.7%,p=0.001),且每个人发生 SH 的次数更多(中位数[IQR]0[0,2] vs. 0[0,0],P<0.001),且更可能为女性(72.7% vs. 52.6%,p=0.036)。社会经济贫困与 IAH(p=0.032)和 SH(p=0.005)有关。IAH 组和有感知组的技术使用情况相同,但报告 SH 的患者更有可能使用多次每日注射(p=0.026)。可检测到的 C 肽浓度较高与 SH 风险降低相关(p=0.04)。
IAH 组与有感知组的胰岛素泵和连续血糖监测使用情况相当。尽管如此,IAH 仍然是 SH 的危险因素,在女性和老年人中更为常见。社会经济贫困与 IAH 和 SH 有关,这使得该人群成为干预的重要目标。